Audit 343794

FY End
2024-06-30
Total Expended
$801,415
Findings
0
Programs
5
Organization: Hepatitis B Foundation (PA)
Year: 2024 Accepted: 2025-02-25
Auditor: Eisneramper LLP

Organization Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
KFS3TBNKPGM7 Patti McAloon Auditee
2154894911 Jimmy Mo Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The accompanying supplementary schedule of expenditures of federal awards (“schedule”) includes the federal grant activity of Hepatitis B Foundation for the year ended June 30, 2024. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (“Uniform Guidance”). Because the schedule presents only a selected portion of the Hepatitis B Foundation, it is not intended to, and does not, present the financial position, changes in net assets, or cash flows of Hepatitis B Foundation. Expenditures reported on the schedule of expenditures of federal awards are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: Auditee used agreed upon rates in the grant agreement.